Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.5c00521
Abstract: While investigating the SAR associated with tasquinimod, whose anticancer activity is primarily derived from inhibition of S100A9 and HDAC4, we designed and prepared several analogues. We identified a potent hit (FB2) that showed cytotoxicity against…
read more here.
Keywords:
microtubule dynamics;
fb2;
mitotic arrest;
tasquinimod ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noab196.302
Abstract: Glioblastoma is the most aggressive and most common primary malignant brain tumor in adults. This disease is still incurable despite multimodal therapies. We evaluated Tasquinimod, an oral HDAC4 inhibitor, in use with oncolytic HSV therapy.…
read more here.
Keywords:
glioblastoma;
therapeutic effect;
tasquinimod;
tasquinimod glioblastoma ... See more keywords